1. Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study 
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G. Godino, PhD, B. Gwen Windham, MD, MHS, Mara McAdams- DeMarco, PhD, Josef Coresh, MD, PhD, Elizabeth Selvin, PhD, Morgan E. Grams, MD, PhD 
American Journal of Kidney Diseases 
Volume 69, Issue 2, Pages (February 2017)
DOI: /j.ajkd
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Adjusted prevalence ratios for frailty status by estimated glomerular filtration rate (eGFR). Prevalence ratios adjusted for age, sex, race-center, education, smoking status, alcohol consumption, body mass index, systolic blood pressure, anemia (hemoglobin), inflammation (C-reactive protein), cardiovascular disease (history of coronary heart disease, peripheral artery disease, heart failure, and stroke), diabetes, hypertension medications use, statin medication use), and albumin-creatinine ratio (log-transformed). Abbreviations: CI, confidence interval; eGFRcr, creatinine-based estimated glomerular filtration rate; eGFRcys, cystatin C−based estimated glomerular filtration rate.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 2
Adjusted prevalence ratios for frailty status by albumin-creatinine ratio (ACR). Prevalence ratios adjusted for age, sex, race-center, education, smoking status, alcohol consumption, body mass index, systolic blood pressure, anemia (hemoglobin), inflammation (C-reactive protein), cardiovascular disease (history of coronary heart disease, peripheral artery disease, heart failure, and stroke), diabetes, hypertension medications use, statin medication use), and estimated glomerular filtration rate. Abbreviation: CI, confidence interval.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 3
Demographically adjusted prevalence ratios (95% confidence intervals [CIs]) of frailty by (A) creatinine-based estimated glomerular filtration rate (eGFRcr) or (B) cystatin C−based eGFR (eGFRcys) and albuminuria category. ∗P≤0.05; ∗∗P≤0.01; ∗∗∗P≤0.001.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions